Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q1 EPS by 41c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.46), $0.41 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Analysts eye Intuit investor day for signs estimates have troughed
• Jackson Financial Inc. (JXN) call put ratio 1 call to 14.6 puts with a focus on September 130 and 135 puts as share price down 4.8%